The treatment of MCL cells with everolimus leads to a rapid dephosphorylation of mTOR and of two of its downstream targets, p70S6 kinase and eIF4E-binding protein (4E-BP1), both involved in the regulation of protein translation. The gene discussed is MTOR; the disease is mantle cell lymphoma.